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Key Points 57 
 58 
Question: Does an initial strategy of a supraglottic airway device for advanced airway 59 
management during non-traumatic out-of-hospital cardiac arrest (OHCA) result in a better 60 
functional outcome compared with tracheal intubation? 61 
 62 
Findings: In this cluster-randomized trial that included 1,523 paramedics and 9,296 patients 63 
with OHCA, favorable functional outcome (modified Rankin Scale 0-3) at hospital discharge 64 
or after 30 days (if still hospitalised) occurred in 6.4% in the supraglottic airway group versus 65 
6.8% in the tracheal intubation group, a difference that was not statistically significant.  66 
 67 
Meaning: In this study, a strategy of supraglottic airway device for advanced airway 68 
management did not provide a superior functional outcome.  69 
 70 
 71 
  72 
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Abstract 73 
 74 
Importance: The optimal approach to airway management during out-of-hospital cardiac 75 
arrest (OHCA) is unknown.  76 
 77 
Objective: To determine whether a supraglottic airway device (SGA) is superior to tracheal 78 
intubation (TI) as the initial advanced airway management (AAM) strategy in adults with non-79 
traumatic OHCA.   80 
 81 
Design, Setting and Participants: Cluster randomized trial of emergency medical services 82 
clinicians (paramedics) from four ambulance services in England covering approximately 21 83 
million people. Patients >18 years old, who had a non-traumatic OHCA and were attended 84 
by a participating paramedic, were enrolled automatically under a waiver of consent between 85 
June 2015 and August 2017. Follow-up ended in February 2018.   86 
 87 
Intervention: Paramedics were randomised 1:1 to use TI (764 paramedics) or SGA (759 88 
paramedics) for their initial AAM.  89 
 90 
Main Outcome Measures: Primary outcome was modified Rankin Scale (mRS) at hospital 91 
discharge or 30 days after OHCA, whichever occurred sooner. mRS was dichotomised; 0-3 92 
(good outcome) or 4-6 (poor outcome; 6=death). Secondary outcomes included ventilation 93 
success, regurgitation and aspiration. 94 
 95 
Results: 9,296 eligible patients (SGA group: 4,886, TI group, 4,410) were enrolled (median 96 
age 73 years; 3,373, 36.3% women), and mRS was known for 9,289. Characteristics were 97 
similar between groups. 6.4% (311/4882) of patients in the SGA group and 6.8% (300/4407) 98 
of patients in the TI group had a good outcome (adjusted risk difference (RD): -0.6%; 95%CI 99 
-1.6% to +0.4%). Ventilation success was higher in the SGA strategy group (SGA: 87.4%; 100 
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4255/4868. TI: 79.0%; 3473/4397; adjusted RD: +8.3%; 95%CI +6.3% to +10.2%), however 101 
patients allocated to TI were less likely to receive AAM (SGA: 85.2%; 4,161/4883. TI: 77.6%; 102 
3,419/4404). Regurgitation and aspiration were not significantly different (regurgitation: SGA, 103 
26.1%, 1268/4865; TI, 24.5%, 1072/4372; adjusted RD =+1.4% 95%CI -0.6% to +3.4%; 104 
aspiration: SGA, 15.1%, 729/4824; TI, 14.9%, 647/4337; adjusted RD=+0.1%, 95%CI -1.5% 105 
to +1.8%). 106 
 107 
Conclusions and Relevance: Among patients with OHCA, randomization to a strategy of 108 
advanced airway management with a supraglottic airway device compared with tracheal 109 
intubation did not result in a favorable functional outcome at 30 days. 110 
 111 
Trial Registration: ISRCTN No: 08256118. 112 
  113 
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Introduction 114 
 115 
Out-of-hospital cardiac arrest (OHCA) is common, sudden and often fatal. In England during 116 
2014, Emergency Medical Services (EMS) attempted resuscitation in almost 30,000 people; 117 
only 25% achieved a return of spontaneous circulation (ROSC), and 8% were discharged 118 
from hospital alive.1 During OHCA few advanced life support (ALS) therapies have been 119 
shown to improve outcome.2 This is partly due to uncertainty about effective treatments, and 120 
partly because it is challenging to conduct high-quality randomized clinical trials (RCTs) in 121 
patients with OHCA. Consequently, many current clinical recommendations are based on 122 
observational studies and expert consensus.3  123 
 124 
Optimal airway management during OHCA is a key area of uncertainty, with very little high-125 
quality research on which to base treatment recommendations.4 Options range from basic or 126 
minimal airway intervention to early advanced procedures that require training and expertise.  127 
 128 
The advanced procedure of tracheal intubation (TI) has been considered a definitive airway 129 
management technique.5 However, large observational studies (>100,000 patients) have 130 
consistently favored basic airway management, e.g. bag-mask ventilation, over TI.6,7 The 131 
introduction of supraglottic airways (SGAs) offers an alternative advanced airway 132 
management (AAM) technique during OHCA. Insertion of a SGA is simpler and faster than 133 
TI,8 and proficiency requires less training and ongoing practice.9 Observational evidence has 134 
suggested a possible survival advantage for TI over SGAs.10 However, a large-scale RCT is 135 
required to identify the optimal approach to AAM during OHCA. 136 
 137 
The objective of this trial was to estimate the difference in modified Rankin Scale (mRS) at 138 
hospital discharge or 30 days post OHCA, if sooner, between groups of patients managed 139 
by paramedics randomized to use either SGA or TI as their initial advanced airway 140 
management strategy following OHCA.  141 
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Methods 142 
 143 
Study Design 144 
 145 
The protocol and statistical analysis plan (SAP) for this parallel two-group multi-center 146 
cluster-RCT are included in the online supplement, and the protocol has been published.11   147 
 148 
Paramedic and Patient Population 149 
 150 
Paramedics were recruited from four large EMS provider organizations (ambulance services) 151 
in England, which cover 21 million people (40% of England’s population). The trial population 152 
was adults who had a non-traumatic OHCA.  153 
 154 
Patient inclusion criteria were: known or believed to be 18 years of age or older; non-155 
traumatic OHCA; attended by a paramedic participating in the trial who was either the first or 156 
second paramedic to arrive at the patient’s side; resuscitation commenced or continued by 157 
EMS clinicians. Patient exclusion criteria were: detained in the Prison Service; previously 158 
recruited to the trial (determined retrospectively); resuscitation deemed inappropriate  159 
(using guidelines based on those of the Joint Royal Colleges Ambulance Liaison 160 
Committee12); advanced airway already in place (inserted by another paramedic, doctor or 161 
nurse) when a paramedic participating in the trial arrived at the patient’s side; known to be 162 
already enrolled in another pre-hospital RCT; patient mouth opening <2 cm.  163 
 164 
Paramedics could not be blinded to their allocation and mechanisms were required to avoid 165 
the risk of differential recruitment by paramedics based on the patient’s perceived likely 166 
outcome. Therefore, every eligible patient attended by a participating paramedic was 167 
automatically enrolled in the study under a waiver of consent provided by the Confidentiality 168 
Advisory Group (CAG: reference 14/CAG/1030). Ethics review and approval was provided 169 
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by South Central - Oxford C Research Ethics Committee (REC: reference 14/SC/1219), 170 
which included a process of written informed consent for participating paramedics. A 171 
disadvantage of automatic enrolment was that enrolled patients might not follow the study 172 
protocol because the enrolling paramedic could not recall the protocol details (attendance at 173 
an OHCA is relatively rare and stressful for paramedics), or the paramedic mistakenly 174 
believed the patient to be ineligible. 175 
 176 
Randomization 177 
 178 
Because OHCA requires immediate treatment, randomizing patients at the point of OHCA 179 
was considered impractical. Therefore, paramedics were randomized to use one of the two 180 
AAM strategies for all eligible patients that they attended. This design, although clustered, 181 
created many clusters with a small average number of patients, minimising the effect of 182 
intra-cluster correlation and the risk of chance imbalances between groups. 183 
 184 
Paramedics were randomised in a 1:1 ratio using a purpose-designed secure internet-based 185 
system.  The random sequence was computer generated in advance using varying block 186 
sizes (range 4-8) and stratified by EMS provider organization (4 levels), paramedic 187 
experience (2 levels) and distance from the paramedic’s base ambulance station to the 188 
usual destination hospital (2 levels). 189 
 190 
Intervention 191 
 192 
The intervention was the insertion of a second generation SGA with a soft non-inflatable cuff 193 
(i-gel: Intersurgical, Wokingham, UK). Because of its speed and ease of insertion, this device 194 
has become the most commonly used SGA during OHCA in England.13,14 The current 195 
standard care pathway is TI using direct laryngoscopy; videolaryngoscopy is not used by 196 
paramedics in England. A standard approach to airway management, from basic to 197 
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advanced techniques, was agreed by participating ambulance services. This included the 198 
use of bag-mask ventilation (BMV) and simple airway adjuncts prior to AAM. Care 199 
proceeded as usual for patients with OHCA enrolled in the trial, apart from the initial AAM. 200 
All other care was delivered according to standard international resuscitation guidelines.3 201 
 202 
Participating paramedics received additional training in their allocated AAM intervention 203 
immediately after randomization. Training comprised theoretical and simulation-based 204 
practice over 1 hour with a brief assessment to confirm competence.  For TI a two-person 205 
technique using an intubating bougie was recommended. End tidal carbon dioxide 206 
monitoring was used to confirm correct device placement in all patients. 207 
 208 
Protocol deviations could arise because paramedics have both strategies available to them. 209 
Usual practice follows a “step-wise” approach from simple to more advanced techniques, but 210 
paramedics have clinical freedom to adapt airway management during OHCA to the patient’s 211 
anatomy, position and perceived needs. The trial protocol specified two attempts using the 212 
allocated strategy before proceeding to the alternative, but paramedics had discretion to 213 
deviate from the protocol on clinical grounds. Allowing discretion was necessary to avoid a 214 
paramedic feeling obliged to undertake an intervention that they believed to be against the 215 
patient’s best interests. This was also necessary to secure REC approval and professional 216 
support.  217 
 218 
Outcomes 219 
 220 
The primary outcome was modified Rankin Scale (mRS) at hospital discharge, or at 30 days 221 
if the patient remained in hospital. Patients were conveyed to and followed up in hospital 222 
where mRS was collected by assessors blinded to treatment allocation. mRS is used widely 223 
in OHCA research,15,16 and is usually dichotomised as good (0-3) or poor outcome/death (4-224 
6; 6 indicates death). The following secondary outcomes were collected for all eligible 225 
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patients, with all but the last 2 reported by participating paramedics: initial ventilation 226 
success, defined as visible chest rise (classified as “yes” when AAM was not used); 227 
regurgitation (stomach contents visible in the mouth or nose) and aspiration (stomach 228 
contents visible below the vocal cords or inside a correctly placed tracheal tube or airway 229 
channel of a SGA) (each classified as “no” when AAM was not used); loss of a previously 230 
established airway (patients with AAM only); sequence of airway interventions delivered 231 
(patients with AAM only); ROSC (i. patients with AAM only for ROSC during airway 232 
management; ii. patients who died at the scene classified as “no” for ROSC at hospital 233 
admission); airway management in place when ROSC was achieved, or resuscitation was 234 
discontinued (patients with AAM only); chest compression fraction (in a sub-set of patients in 235 
two EMS provider organizations); time to death. 236 
 237 
Good quality, continuous CPR is associated with increased survival and improved function 238 
following OHCA, and the concept of compression fraction has been developed to 239 
standardise its measurement.17  Compression fraction was therefore measured and 240 
compared in a sub-set of patients in two ambulance services using the “CPR Card” (Laerdal; 241 
Stavanger, Norway), a small disposable device placed in the centre of the patient’s chest 242 
during CPR. The device gives no feedback to the user but records data that can be retrieved 243 
subsequently.  244 
 245 
Resource use to support a cost effectiveness analysis and longer-term function were also 246 
collected. These data will be reported separately.  247 
 248 
Sample Size 249 
 250 
In a previous feasibility study, 9% of patients survived to hospital discharge.18 No data were 251 
available for mRS. However, death and poor functional outcome after OHCA are closely 252 
related because death is the most common outcome.16 A 2% improvement in the proportion 253 
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of patients achieving a good outcome (mRS 0-3) was judged to be clinically important, and 254 
consistent with the 2.4% difference in survival to hospital discharge between TI and SGAs 255 
observed in retrospective data.19 This meant that 9,070 patients in total were needed to 256 
detect a difference of 8% vs 10% at the 5% significance level and 90% power, after allowing 257 
for clustering.11  258 
 259 
Statistical Analysis 260 
 261 
Analysis of the primary outcome, and exploratory analyses of secondary outcomes, were 262 
performed according to a pre-specified statistical analysis plan (SAP), which was finalised 263 
before data lock and any comparative analysis, but after the end of recruitment due to staff 264 
changes in the statistical team.  Some typographical errors were corrected in version 2 and 265 
some points were clarified, but no substantive changes were made.  No comparative post-266 
hoc analyses were performed.   267 
 268 
The primary analyses included all eligible patients with outcome data available (Tables 269 
report details), except for the following secondary outcomes which only applied to those who 270 
received AAM: loss of a previously established airway; ROSC during airway management; 271 
airway management in place when ROSC was achieved or resuscitation was discontinued. 272 
Chest compression fraction was only measured in small subset of patients. Patients were 273 
grouped by the allocation of the first participating paramedic on scene (main analyses).  274 
Analyses were adjusted for stratification factors as fixed effects. For binary outcomes, 275 
mixed-effects logistic regression estimated odds ratios for the primary analysis, with 276 
paramedic fitted as a random effect.  Risk differences and risk ratios were also estimated 277 
using generalised linear regression, with standard errors calculated using a sandwich 278 
estimator to allow for clustering. Risk ratios are reported in the Supplement (eTable 7). For 279 
time-to-event outcomes, Cox proportional-hazards regression was used.  The proportionality 280 
assumption, checked using Schoenfeld residuals, was met. 281 
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 282 
The level of missing data is given in footnotes to the Tables. Multiple imputation was not 283 
considered as the level of missing data was 7 patients (0.08%) for the primary outcome and 284 
less than 1.5% for all but one secondary outcome which had 6.4% missing data. 285 
 286 
Two pre-specified exploratory sub-group analyses were performed for the primary outcome; 287 
i) Utstein comparator group (OHCA with a likely cardiac cause that is witnessed and has an 288 
initial rhythm amenable to defibrillation20) versus non-comparator group, and ii) OHCA 289 
witnessed by EMS clinician or not.  The treatment effect in sub-groups was compared by 290 
testing for an interaction between paramedic allocation and the sub-group variable.  291 
 292 
Three pre-specified exploratory sensitivity analyses were performed for the primary 293 
outcome. The first extended the population to include patients attended by a participating 294 
paramedic who were not resuscitated (i.e. trial patients plus non-resuscitated patients).  This 295 
was prompted by feedback from a pre-planned closed interim analysis of half the sample 296 
considered by the Data Monitoring and Safety Committee.  The second and third sensitivity 297 
analyses, restricted to the cohort of patients who received AAM (as allocated and treatment 298 
received comparisons), were planned from the outset. 299 
 300 
A 5% significance level (two-sided) was used. Groups were compared using Wald tests. No 301 
adjustment was made for multiple testing, so that secondary endpoints should be considered 302 
exploratory 21. All analyses were performed using Stata version 15.1 (StataCorp). 303 
 304 
 305 
  306 
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Results 307 
 308 
Participants, Baseline Characteristics and Protocol Adherence 309 
 310 
Overall, 1,523 paramedics were recruited and randomized. Of 13,462 potentially eligible 311 
patients attended by a participating paramedic between June 2015 and August 2017, 4,166 312 
(31%) were excluded and 9,296 (69%) were enrolled (Figure 1). Enrolled patients were 313 
conveyed to 95 hospitals and followed-up to hospital discharge. Paramedics’ allocation was 314 
balanced (SGA: 759; TI: 764), but there were more patients in the SGA (n=4,886) than the 315 
TI group (n=4,410). The proportions of patients with OHCA resuscitated (SGA: 51.6%, 316 
7007/13587; TI: 50.5%, 6455/12789) and eligible (SGA; 69.7%, 4886/7006; TI: 68.3%; 317 
4410/6454) were similar in the two groups. 318 
 319 
Patient characteristics and cardiac arrest details were balanced between the two groups 320 
(Table 1; eTables 1 and 2).  321 
 322 
Fewer patients allocated to TI received AAM (77.6%; 3,419/4404, vs. 85.2%; 4,161/4883). TI 323 
patients were also more likely to crossover to SGA as a result of clinical decision-making by 324 
the paramedic on scene (Figure 2; eFigure 1, eTable 3).  325 
 326 
Primary Outcome 327 
 328 
Primary outcome data were available for 99.9% (9,289/9,296) of patients (Table 2); 6.4% 329 
(311/4882) in the SGA group and 6.8% (300/4407) in the TI group had a good outcome 330 
(mRS 0-3, odds ratio (OR) 0.918, 95% confidence interval (95%CI) 0.77-1.09; risk difference 331 
(RD, SGA minus TI) -0.6%, 95%CI -1.6% to +0.4%; Figure 3 and eFigure 2). 332 
 333 
Exploratory Sensitivity Analyses 334 
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 335 
Including patients attended by a participating paramedic who were not resuscitated did not 336 
change the conclusion (SGA, 2.7%, 311/11462; TI, 2.8%, 300/10741; OR=0.959; 95%CI: 337 
0.81-1.14. RD=-0.2%; 95%CI -0.6% to +0.3%; Figure 3, eTable 4).  However, in the 7,576 338 
(81%) patients who received AAM more patients in the SGA group had a good outcome 339 
(SGA, 3.9%, 163/4158; TI, 2.6%, 88/3418; OR=1.57, 95%CI 1.18-2.07; RD=+1.4%; 95%CI 340 
+0.5% to +2.2%).  This effect was also observed in the analysis with patients grouped 341 
according to the first AAM intervention received (SGA, 4.2%, 193/4630; TI, 2.0%, 58/2838; 342 
OR=2.06, 95%CI 1.51-2.81; RD=+2.1%, 95%CI +1.2% to +2.9%). 343 
 344 
Exploratory Subgroup Analyses 345 
 346 
There was no interaction between allocation and either subgroup (Figure 3; Utstein 347 
comparator group vs not, p=0.24; cardiac arrest witnessed by EMS clinician vs not, p=0.24).  348 
 349 
Secondary Outcomes 350 
 351 
Secondary outcomes are shown in Table 2 and eTable 5. The SGA treatment strategy was 352 
significantly more successful in achieving ventilation after up to two attempts (SGA, 87.4%, 353 
4255/4868; TI, 79.0%, 3473/4397; OR=1.92, 95%CI 1.66-2.22; RD=+2.1%, 95%CI +1.2% to 354 
+2.9%). Regurgitation and aspiration at any time (i.e. before and/or after AMM) were similar 355 
(regurgitation: SGA, 26.1%, 1268/4865; TI, 24.5%, 1072/4372; OR=1.08, 95%CI 0.96-1.20; 356 
RD =+1.4% 95%CI -0.6% to +3.4%; aspiration: SGA, 15.1%, 729/4824; TI, 14.9%, 357 
647/4337; OR=1.01, 95%CI 0.88-1.16; RD=+0.1%, 95%CI -1.5% to +1.8%).  358 
 359 
The median time to death was not significantly different between the two groups (SGA: 67 360 
minutes, n=4871. TI: 63 minutes, n=4400), and neither was the compression fraction in a 361 
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very small sample of 66 patients (SGA, median 86%, IQR 81-91%, n=34; TI, median 83%, 362 
IQR 74%-89%, n=32; p=0.14; eTable 6).  363 
 16 
 
Discussion 364 
In this pragmatic cluster RCT no significant difference was found between TI and SGA in the 365 
primary outcome of good outcome after OHCA for all trial patients.  366 
 367 
Patients with a short duration of cardiac arrest and who receive bystander resuscitation 368 
and/or defibrillation are considerably more likely to survive and are also less likely to require 369 
AAM.22 This problem of confounding by indication is an important limitation of many large 370 
observational studies that show an association between AAM and poor outcome in OHCA.23 371 
This study found that 21.1% (360/1704) of patients who received no AAM achieved a good 372 
outcome compared to 3.3% (251/7576) of patients who received AAM.  373 
 374 
Paramedics allocated to TI were less likely to use AAM than paramedics allocated to SGA. 375 
TI is a more complex skill than SGA insertion and requires two practitioners, additional 376 
equipment and good access to the patient’s airway,24 yet OHCA often occurs in locations 377 
where patient access is challenging. TI has been associated with potential harms including 378 
unrecognised oesophageal intubation, lengthy pauses in chest compressions and over-379 
ventilation.25,26 No evidence of a difference in compression fraction was found in a small sub-380 
sample of enrolled patients, but the potential for harm associated with TI persists.  381 
 382 
At the outset, it was expected that most patients with a favourable outcome would not 383 
receive AAM, and that some crossover would occur. For these reasons, two exploratory 384 
sensitivity analyses were pre-specified only in patients who received AAM, even though 385 
these analyses are susceptible to bias.27  Patients who received AAM were similar in the two 386 
groups (eTable 1; eTable 2), and a strategy of SGA first was associated with better 387 
outcomes whenever AAM was undertaken by a trial paramedic (eTable 4), but the difference 388 
between groups was less than the pre-specified clinically important 2% difference and less 389 
than the minimal important difference of approximately 3% reported by others.28 The SGA 390 
first strategy also achieved initial ventilation success more often, although regurgitation and 391 
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aspiration during or after AAM were significantly more common in the SGA group. 392 
Conversely, patients in the TI group were significantly more likely to regurgitate and aspirate 393 
before AAM, possibly due to less frequent use of advanced techniques to secure the airway 394 
in this group and the increased time required for TI compared to insertion of a SGA. 395 
 396 
A recent RCT of French and Belgian patients with OHCA, comparing BMV with TI delivered 397 
by physicians as part of an EMS team, proved inconclusive.29 To our knowledge, no RCT 398 
has compared BMV with an SGA in patients with OHCA. Reported rates of ventilation and TI 399 
success have been higher in previous studies,29,30,31 but these have been based on selected 400 
populations and practitioners with greater training and experience, including physicians. This 401 
study reflects both the reality of current paramedic practice in England, and the challenges of 402 
airway management in a patient group where regurgitation and poor airway access are 403 
common.  404 
 405 
Loss of a previously established airway occurred twice as frequently in the SGA group than 406 
in the TI group.  There are some cardiac arrest patients for whom effective ventilation cannot 407 
be achieved with basic airway management techniques or an SGA, and for whom TI may be 408 
the only way of achieving effective ventilation. The exact role of different advanced airway 409 
management techniques in adults with OHCA, and the associated implications for skill 410 
acquisition and maintenance, remain to be determined. 411 
 412 
Limitations 413 
 414 
This study has several limitations. First, the trial population included patients who did and did 415 
not receive AAM, and the use of AAM was greater among paramedics in the SGA group 416 
compared to those in the TI group which could result in confounding by indication.32 Second, 417 
there was an imbalance in the number of patients in the two groups, probably due to unequal 418 
distribution of high-recruiting paramedics in the two groups; it was not possible to stratify for 419 
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this because high-recruiting paramedics could not be identified in advance.  Third, there was 420 
crossover between groups, which was inevitable on practical and ethical grounds.  Fourth, 421 
although other elements of care (e.g. initial basic airway management and subsequent on-422 
scene and in-hospital care, such as targeted temperature management and access to 423 
angiography) followed established guidelines, differences in these factors between groups 424 
could have influenced the findings. Fifth, the participating paramedics were volunteers, and 425 
their airway skills may not be representative of those who chose not to take part. Sixth, the 426 
findings are applicable to use of the trial SGA in countries with similar EMS provision to 427 
England, where paramedics attend most OHCAs. The findings may not be applicable in 428 
countries with physician-led EMS provision or to other SGAs which may have different 429 
characteristics. However, the principles underpinning the insertion and function of all SGAs 430 
are similar.     431 
 432 
Conclusions 433 
 434 
Among patients with OHCA, randomization to a strategy of advanced airway management 435 
with a supraglottic airway device compared with tracheal intubation did not result in a 436 
favorable functional outcome at 30 days. 437 
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Table 1: Patient demography and cardiac arrest details  
 
All trial patients 
Randomised to TI 
(n=4,410)
Randomised to  
Trial SGA  
(n=4,886) 
 n % n % 
DEMOGRAPHY  
Male gender 2791/4410 63.3% 3132/4886 64.1% 
Age (median, IQR) 74 (62, 83) 73 (61, 82) 
INITIAL CARDIAC ARREST 
DETAILS  
Time from 999 call to first EMS 
clinician arrival (mins; median, IQR) 8 (5, 11) 7 (5, 11) 
Time from first EMS clinician arrival 
to trial EMS clinician arrival (mins; 
median, IQR)[1] 0 (0, 4) 1 (0, 4) 
Presenting rhythm  
 Asystole 2356/4316 54.6% 2597/4791 54.2% 
 VF 979/4316 22.7% 1094/4791 22.8% 
 Pulseless VT 44/4316 1.0% 39/4791 0.8% 
 PEA 937/4316 21.7% 1061/4791 22.1% 
Arrest witnessed 2788/4407 63.3% 3101/4883 63.5% 
 By bystander 2231/2788 80.0% 2493/3100 80.4% 
 By EMS clinician 557/2788 20.0% 607/3100 19.6% 
Bystander/responder CPR before 
EMS clinician arrival 2774/4406 63.0% 3149/4883 64.5% 
Bystander/responder defibrillation 
before EMS clinician arrival[2] 146/4390 3.3% 176/4863 3.6% 
 If yes, ROSC achieved 20/146 13.7% 27/176 15.3% 
ON ARRIVAL OF STUDY EMS CLINICIAN
Airway management in progress 1384/4389 31.5% 1463/4863 30.1% 
 BVM only 273/1383 19.7% 307/1463 21.0% 
 OPA and BVM 766/1383 55.4% 875/1463 59.8% 
 NPA and BVM 11/1383 0.8% 11/1463 0.8% 
 Trial SGA 262/1383 18.9% 190/1463 13.0% 
 Intubation 3/1383 0.2% 3/1463 0.2% 
 Other SGA 44/1383 3.2% 57/1463 3.9% 
 Mouth to mouth 8/1383 0.6% 10/1463 0.7% 
 Face shield/pocket mask 5/1383 0.4% 4/1463 0.3% 
 Suction 3/1383 0.2% 2/1463 0.1% 
 Other 8/1383 0.6% 4/1463 0.3% 
Successful ventilations ongoing 1110/1372 80.9% 1154/1455 79.3% 
Patient had ROSC on arrival 300/4393 6.8% 328/4862 6.8% 
TI=Tracheal Intubation, SGA=Supraglottic Airway, IQR=Interquartile range, VF=Ventricular Fibrillation, VT=Ventricular 
Tachycardia, PEA=Pulseless Electrical Activity, EMS=Emergency Medical Services, CPR=Cardiopulmonary Resuscitation, 
ROSC=Return of Spontaneous Circulation, BVM=Bag Valve Mask, OPA=Oropharyngeal Airway, NPA=Nasopharyngeal 
Airway. 
Missing data (randomised to TI, randomised to trial SGA): [1]4 patients (3, 1). 
[2]Where bystander/responder defibrillation occurred before EMS clinician arrival this was achieved using an automated external 
defibrillator (AED) available at scene.  
All patients are grouped by the allocation of the first study EMS clinician on scene.
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Table 2: Primary outcome (modified Rankin Scale at hospital discharge/30 days), survival status and main secondary 
outcomes 
 
All trial patients
Randomised to TI  
(n=4,410)
Randomised to  
Trial SGA  
(n=4,886) Estimate 
(95% CI) p-value ICC
Risk difference 
estimate 
(95% CI)
p-value 
 n % n %  
PRIMARY OUTCOME       
mRS (0 to 3; good recovery) 
300/4407 6.8% 311/4882 6.4% 
OR=0.92 
(0.77, 1.09) 0.33 0.05
RD=-0.006  
(-0.016, 0.004) 0.24 
 0 (no symptoms) 124/4407 2.8% 117/4882 2.4%      
 1 48/4407 1.1% 41/4882 0.8%      
 2 50/4407 1.1% 58/4882 1.2%      
 3 78/4407 1.8% 95/4882 1.9%      
 4 46/4407 1.0% 45/4882 0.9%      
 5 27/4407 0.6% 39/4882 0.8%      
 6 (deceased) 4034/4407 91.5% 4487/4882 91.9%      
SECONDARY OUTCOMES      
Survival status:      
Died at scene 2488/4407 56.5% 2623/4882 53.7%      
Died prior to ICU admission 1058/4407 24.0% 1226/4882 25.1%      
Died prior to ICU discharge 369/4407 8.4% 503/4882 10.3%      
Died prior to hospital discharge 120/4407 2.7% 138/4882 2.8%      
Survived to 30 days/hospital 
discharge 372/4407 8.4% 392/4882 8.0% 
     
Time to death (minutes;  median, 
IQR, n) [1] 63 (41,216) 4400 67 (41, 267) 4871  
HR=0.97 
(0.93, 1.02) 0.22
   
Time to death 0-72 hours 
(minutes; n, median, IQR) [1] 63 (41,205) 4400 67 (41, 246) 4871  
HR=0.96 
(0.92, 1.00) 0.07
   
72 hour survival 
575/4395 13.1% 664/4872 13.6% 
OR=1.04 
(0.92, 1.18) 0.54 0.02
RD=0.004      
(-0.010, 0.019) 0.54 
Initial ventilation success (up to two 
attempts at AAM) 3473/4397 79.0% 4255/4868 87.4% 
OR=1.92  
(1.66, 2.22) <0.001 0.12
RD=0.083  
(0.063, 0.102) <0.001 
 TI 1891/2723 69.4% 92/116 79.3%  
 Trial SGA 542/617 87.8% 3412/3994 85.4%  
 Other SGA 55/72 76.4% 29/36 80.6%  
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All trial patients
Randomised to TI  
(n=4,410)
Randomised to  
Trial SGA  
(n=4,886) Estimate 
(95% CI) p-value ICC
Risk difference 
estimate 
(95% CI)
p-value 
 n % n %  
Any loss of a previously established 
airway[2] 153/3081 5.0% 412/3900 10.6% 
OR=2.29  
(1.86, 2.82) <0.001 0.07
RD=0.059  
(0.046, 0.072) <0.001 
 TI 70/2149 3.3% 33/570 5.8%  
 Trial SGA 84/981 8.6% 389/3455 11.3%  
 Other SGA 5/171 2.9% 3/33 9.1%  
Regurgitation at any time 
1072/4372 24.5% 1268/4865 26.1% 
OR=1.08 
(0.96, 1.20) 0.21 0.06
RD=0.014  
(-0.006, 0.034) 0.17 
Aspiration at any time 
647/4337 14.9% 729/4824 15.1% 
OR=1.01 
(0.88, 1.16) 0.84 0.08
RD=0.001 
(-0.015, 0.018) 0.86 
Regurgitation before initial SGA/TI 
attempt 923/4379 21.1% 846/4869 17.4%  
Aspiration before initial SGA/TI 
attempt 589/4355 13.5% 532/4840 11.0%  
Regurgitation during or after initial 
SGA/TI attempt 543/4361 12.5% 875/4857 18.0%  
Aspiration during or after initial 
SGA/TI attempt 304/4344 7.0% 473/4829 9.8%  
Admitted to ED/hospital 1922/4410 43.6% 2263/4886 46.3%      
ROSC on ED/hospital arrival 1249/4404 28.4% 1495/4880 30.6% 
OR=1.12 
(1.02, 1.23) 0.02 0.01
RD=0.022 
(0.003, 0.042) 0.03 
Survived to ED discharge 861/1919 44.9% 1033/2259 45.7%      
TI=Tracheal Intubation, SGA=Supraglottic Airway device, CI=Confidence Interval, ICC=Intracluster correlation coefficient, OR=odds ratio, RD=risk difference, HR=Hazard ratio, mRS=modified 
Rankin Scale score, ICU=Intensive Care Unit, IQR=Interquartile Range, AAM=advanced airway management, ED=Emergency department, ROSC=Return of spontaneous circulation, 
EMS=Emergency medical services. 
Note: 
Odds ratios and risk differences are adjusted for stratification factors fitted as fixed effects. Odds ratios were obtained from a mixed effects logistic regression model with study EMS clinician fitted as 
a random effect. Risk differences were obtained by fitting a generalised linear model (binomial family and identity link) with standard errors adjusted for clustering. The hazard ratios are adjusted for 
EMS clinician experience and distance from usual hospital and stratified by EMS provider organisation with standard errors adjusted for clustering. Wald p-values are displayed. 
[1] Patients who survived to ICU discharge but did not consent to active or passive follow-up were censored at ICU discharge because research approvals did not permit analysis of subsequent data, 
apart from the mRS. 
[2]Trial patients with at least one AAM attempt only 
All patients are grouped by the allocation of the first study EMS clinician on scene. 
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Figure 1  Flow of study EMS clinicians and patients  
 
Submitted separately. 
 
 
Figure 2 Interventions received and patient outcome by study allocation 
 
Submitted separately. 
 
 
Figure 3 Forest plot of primary outcome results (mRS at hospital discharge/30 days) 
 
Submitted separately, notes for figure below 
 
mRS=Modified Rankin Scale, TI=Tracheal Intubation, SGA=Supraglottic Airway device, OR=Odds Ratio, CI=Confidence Interval, EMS=Emergency Medical Services.  
Odds ratios are estimated from a mixed effects logistic regression model, with stratification factors fitted as fixed effects and study EMS clinician as a random effect). Wald p-values are displayed. 
The size of the point estimate (grey dot) is proportional to the number of patients included 
Note:  
Patients are grouped by the allocation of the first study EMS clinician on scene. 
eFigure 2 displays the breakdown of the mRS scores in the form of horizontally stacked bar charts. 
n/N is displayed where n is the number of patients with a score of 0-3 (good recovery) and N is the total number in that group. 
[1] All trial patients.  
[2] All trial patients. Patients whose cardiac arrest was recorded as not witnessed are included in the Utstein non-comparator group  
[3] All trial patients. Patients whose cardiac arrest was recorded as not witnessed are included in the not witnessed by ambulance staff group 
[4] All trial patients plus patients attended by a study EMS clinician who were not resuscitated.  
Missing data (randomised to TI, randomised to SGA): [1] 7 patients (3, 4). [2] 103 patients (52, 51). [3] 7 patients (3, 4). [4] 4 patients (1, 3).  
 
 
